Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches

L Costantino, G Rastelli, P Vianello… - Medicinal research …, 1999 - Wiley Online Library
Despite recent advances both in the chemistry and molecular pharmacology of antidiabetic
drugs, diabetes still remains a life‐threatening disease, which tends to spread all over the …

New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications

L Costantino, G Rastelli, G Cignarella… - Expert Opinion on …, 1997 - Taylor & Francis
The results of recent clinical trials emphasise the importance of an improved glycaemic
control in diabetic patients in order to prevent or at least to delay long-term complications …

Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications

PF Kador, JH Kinoshita… - Journal of Medicinal …, 1985 - ACS Publications
Although the administration of insulin can prolong the life of diabetics, its use to date has not
prevented the debilitating, late-onset complications associated with this disease. Diabetic …

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

S Miyamoto - Expert Opinion on Therapeutic Patents, 2002 - Taylor & Francis
The development of long-term diabetic complications in diabetes patients is considered to
be closely related to hyperglycaemia. Aldose reductase was first found to be implicated in …

New approaches for treatment in diabetes: aldose reductase inhibitors

N Hotta - Biomedicine & pharmacotherapy, 1995 - Elsevier
The etiology of late-onset diabetic complications is not clear yet but is probably multifactorial,
and related to the quality of glycemic control [l-3] and to genetic factors. Several general …

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E Boel, J Selmer, HJ Flodgaard, T Jensen - Journal of Diabetes and its …, 1995 - Elsevier
Patients suffering from the severe complications associated with both insulin-(IDDM) and
noninsulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …

[图书][B] Aldose reductase inhibitors as potential therapeutic drugs of diabetic complications

C Zhu - 2013 - books.google.com
Diabetes mellitus has become a major health threat as a global rise in it has been seen. The
chronic disease has afflicted over 171 million people worldwide in 2000 and the incidence is …

Pharmacological approaches to the treatment of diabetic complications

L Costantino, G Rastelli, MC Gamberini… - Expert Opinion on …, 2000 - Taylor & Francis
Diabetes is often accompanied by several long-term complications such as neuropathy,
nephropathy, retinopathy, cataract and angiopathy; their occurrence has been linked to the …

Aldose Reductase: A cause and a potential target for the treatment of diabetic complications

S Thakur, SK Gupta, V Ali, P Singh, M Verma - Archives of Pharmacal …, 2021 - Springer
Diabetes mellitus, a disorder of metabolism, results in the elevation of glucose level in the
blood. In this hyperglycaemic condition, aldose reductase overexpresses and leads to …

Aldose reductase inhibitors as a new approach to the treatment of diabetic complications

CA Lipinski, NJ Hutson - Annual Reports in Medicinal Chemistry, 1984 - Elsevier
Publisher Summary Several excellent reviews of the recent advances in the understanding
of the biochemical events contributing to the pathophysiology of diabetic complications have …